Raymond James Financial’s Calumet Specialty Products CLMT Stock Holding History

Raymond James Financial’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.94M	Sell	165,035 -22,870	-12%	-$769K	﹤0.01%	2595
2026 Q1	$6.75M	Sell	187,905 -308,056	-62%	-$7.98M	﹤0.01%	2351
2025 Q4	$9.85M	Sell	495,961 -22,095	-4%	-$425K	﹤0.01%	1982
2025 Q3	$9.45M	Sell	518,056 -15,965	-3%	-$263K	﹤0.01%	1964
2025 Q2	$8.41M	Sell	534,021 -8,332	-2%	-$106K	﹤0.01%	2002
2025 Q1	$6.88M	Buy	542,353 +21,704	+4%	+$341K	﹤0.01%	2094
2024 Q4	$11.5M	Buy	+520,649	New	+$10.9M	﹤0.01%	1737

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raymond James Financial's CLMT Position: Q2 2026 in Review

Raymond James Financial reduced its Calumet Specialty Products (CLMT) stake by 12% in Q2 2026, selling an estimated $769K and leaving 165,035 shares worth $5.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2595.

Raymond James Financial first reported a position in CLMT in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.5M in Q4 2024. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

Raymond James Financial held 165,035 shares of Calumet Specialty Products worth $5.94M as of Q2 2026.
Raymond James Financial sold 22,870 Calumet Specialty Products shares in Q2 2026, an estimated $769K.
Calumet Specialty Products made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2595 holding.
Raymond James Financial first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 7 quarters since.
Raymond James Financial's Calumet Specialty Products position peaked at $11.5M in Q4 2024.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.